Dave Elias & Associates

Investment Approach and PhilosophyDave Elias & Associates believes that an investment approach focused on smaller capitalized companies, early stage companies or larger private companies is the best way to identify and seek to profit from undiscovered or untapped deep value investment opportunities. We find these opportunities among companies we believe to be "under-valued," "under-resourced" or poorly governed, such as early stage development companies with growth potential, where the various stages of the company’s evolution provide a range of investment opportunities, or in larger private companies with valuable intellectual property, strong brand recognition, assets or products that generate significant revenue but have lacked fiscal discipline, governance, strategy, or become mired in debt. The value of these companies may significantly appreciate as a result of changes in management, governance, strategy or corporate and/or financial restructuring.
Elias favors opportunities to work with companies in a mutually beneficial and cooperative environment but will pursue aggressive activist investing in particular cases. In situations where management has repeatedly failed to execute on a business plan or make the desired improvements to the company's corporate governance, or there are signs that management may have internal conflicts of interest or are taking actions that have a detrimental impact on the company's operations or performance, Elias shall seek to implement the desired improvements through ongoing discussions with management. At times, when progress is not made through these discussions, Elias may often seek to take other actions, such as seeking board representation or calling a special shareholder meeting.
Late stage pre-IPO private equity allocations or bridge loans are made with the intention of profiting from a post-IPO sale of the holding, rather than planning for it to be a buy and hold long-term (i.e. 2 years+) investment. Private investments in public companies are made in cases where there are catalysts or the potential for catalysts (i.e. completion of later phases of drug trials) occurring in the near future (i.e. 6 to 12 months) to propel the stock forward and the pricing of securities is at a discount to market value at the time of investment.
David ELias
Founder, President & Chief Investment Officer, Dave Elias & Associates (dba Elias Asset Management). Prior to Dave Elias & Associates, David was CEO of DME Securities LLC and Co-Partner at DME Capital LLC.
DME Securities was a licensed broker-dealer & investment banking firm, Member of the New York Stock Exchange and FINRA. DME Capital was a private equity fund.
During his tenure as CEO, DME Securities grew into a premiere broker-dealer on the floor of the New York Stock Exchange and handled trades for some of the largest financial institutions in the world. Clients included investment banks, hedge funds, brokerage houses, as well as working with and along-side traders, brokers and specialists on the floor of the NYSE. David was a founding board member of IBAC (Independent Broker Action Committee) designed to protect rights of independent floor brokers of the NYSE.
INVESTMENTS
Open Market Private Stock Transactions Private Placements Equity, Debt mixture of both IPO's Public and Private Companies
MERCHANT BANKING
Dave Elias & Associates will assume a Merchant Banking role to support its portfolio companies by raising capital from like-minded instititional investors.
Contact
david@daveelias.com

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories

Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.